Prevalence of known mutations in the familial Mediterranean fever gene (MEFV) in various carrier screening populations

Genetics in Medicine

Volumn 10, Issue 5, 2008, Pages 349-352

  Mikula, Mario ^a   Buller, Arlene ^a   Sun, Weimin ^a   Strom, Charles M ^a  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Familial mediterranean fever; Frequency; MEFV

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; DNA;

ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA ISOLATION; FAMILIAL MEDITERRANEAN FEVER; FAMILIAL MEDITERRANEAN FEVER GENE; GENE; GENE FREQUENCY; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE; HUMAN; JEW; LABORATORY TEST; MUTATIONAL ANALYSIS; PENETRANCE; PREVALENCE; UNITED STATES;

CYSTIC FIBROSIS; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; FACTOR V; FAMILIAL MEDITERRANEAN FEVER; GENETIC SCREENING; HETEROZYGOTE; HUMANS; JEWS; MEDITERRANEAN REGION; MUTATION; PENETRANCE; UNITED STATES; VARIATION (GENETICS);

EID: 44449128233     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181723cc8     Document Type: Article

References (10)

1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967;43:227-253.
2. Livneh A, Langevitz P, Zemer D, Zaks N, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879-1885.
3. Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, et al. MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 1999;65:88-97.
4. Richards N, Schaner P, Diaz A, Stuckey J, et al. Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J Biol Chem 2001;276:39320-39329.
5. Bakkaloglu A. Familial Mediterranean fever. Pediatr Nephrol 2003;18:853-859.
6. Stoffman N, Magal N, Shohat T, Lotan R, et al. Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups. Eur J Hum Genet 2000;8:307-310.
7. Samuels J, Aksentijevich I, Torosyan Y, Centola M, et al. Familial Mediterranean fever at the millennium: clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Balt) 1998;77:268-297.
8. Ben-Chetrit E, Lerer I, Malamud E, Domingo C, et al. The E148Q mutation in the MEFV gene: is it a disease-causing mutation or a sequence variant? Hum Mutat 2002;15:385-386.
9. Tchernitchko D, Legendre M, Cazeneuve C, Delahaye A, et al. The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever. Hum Mutat 2000;24:339-340.
10. Aksentijevich I, Torosyan Y, Samuels J, Centola M, et al. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 1999;64:949-962.